Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiko Maeda

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
International Review of Neurobiology|July 18, 2009
PPAR and PainTakehiko Maeda, Shiroh Kishioka
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 4, 2014
[Study on novel mechanism underlying analgesia targeting TRPV1]Takehiko Maeda, Masanobu Ozaki
Current Opinion in Investigational Drugs (London, England : 2000)|January 8, 2009
The pharmacological mechanisms of electroacupunctureYohji Fukazawa, Takehiko Maeda, Shiroh Kishioka
Neuroscience Letters|September 6, 2016
Cancer pain relief achieved by disrupting tumor-driven semaphorin 3A signaling in miceTakehiko Maeda, Daisuke Yamada, Kohichi Kawahara
Biochemical and Biophysical Research Communications|June 2, 2016
mTORC1 is a critical mediator of oncogenic Semaphorin3A signalingDaisuke Yamada, Kohichi Kawahara, Takehiko Maeda
Neuroscience Letters|September 16, 2008
Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in miceNorikazu Kiguchi, Takehiko Maeda, Yuka Kobayashi, et al.
Biochemical and Biophysical Research Communications|November 6, 2016
Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancerDaisuke Yamada, Kensuke Takahashi, Kohichi Kawahara, et al.
Biochemical and Biophysical Research Communications|October 9, 2016
Plexin A1 signaling confers malignant phenotypes in lung cancer cellsDaisuke Yamada, Satoshi Watanabe, Kohichi Kawahara, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Evaluation of a novel aminopeptidase N inhibitor, in vitro, using two assay systemsLuqing Shang, Takehiko Maeda, Wenfang Xu, et al.
Bioscience, Biotechnology, and Biochemistry|February 12, 2016
Tumor cell-derived secretory factor downregulates Semaphorin-3a in osteoblasts by activating mammalian target of rapamycin pathwayDaisuke Yamada, Kohichi Kawahara, Masanobu Ozaki, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
International Review of Neurobiology|July 18, 2009
PPAR and PainTakehiko Maeda, Shiroh Kishioka
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 4, 2014
[Study on novel mechanism underlying analgesia targeting TRPV1]Takehiko Maeda, Masanobu Ozaki
Current Opinion in Investigational Drugs (London, England : 2000)|January 8, 2009
The pharmacological mechanisms of electroacupunctureYohji Fukazawa, Takehiko Maeda, Shiroh Kishioka
Neuroscience Letters|September 6, 2016
Cancer pain relief achieved by disrupting tumor-driven semaphorin 3A signaling in miceTakehiko Maeda, Daisuke Yamada, Kohichi Kawahara
Biochemical and Biophysical Research Communications|June 2, 2016
mTORC1 is a critical mediator of oncogenic Semaphorin3A signalingDaisuke Yamada, Kohichi Kawahara, Takehiko Maeda
Neuroscience Letters|September 16, 2008
Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in miceNorikazu Kiguchi, Takehiko Maeda, Yuka Kobayashi, et al.
Biochemical and Biophysical Research Communications|November 6, 2016
Autocrine Semaphorin3A signaling is essential for the maintenance of stem-like cells in lung cancerDaisuke Yamada, Kensuke Takahashi, Kohichi Kawahara, et al.
Biochemical and Biophysical Research Communications|October 9, 2016
Plexin A1 signaling confers malignant phenotypes in lung cancer cellsDaisuke Yamada, Satoshi Watanabe, Kohichi Kawahara, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 18, 2008
Evaluation of a novel aminopeptidase N inhibitor, in vitro, using two assay systemsLuqing Shang, Takehiko Maeda, Wenfang Xu, et al.
Bioscience, Biotechnology, and Biochemistry|February 12, 2016
Tumor cell-derived secretory factor downregulates Semaphorin-3a in osteoblasts by activating mammalian target of rapamycin pathwayDaisuke Yamada, Kohichi Kawahara, Masanobu Ozaki, et al.
Pageof 5